I do wish this was around when my late mother had diabetes, but maybe more circulation sores in her feet. Any improvement on the normal treatment or placebo is certainly not a loss, even if not a wow factor with such small numbers.
I think PNV is leading the way with wound treatment and medical volume and revenue for them looks great.
Cyp has a future, in the future I would hope, and I will keep buying and selling when you can like yesterday just for a weekend seafood platter. You can't buy or sell big on this as it is snail.
It pulls it's head in with trade just like a snail as sits for months until it tastes some rain.
Even then you can't ecpect to buy or sell in anything but bottom of the bag coins.
Ann: Encouraging Initial Data from CYP-006TK DFU Trial, page-45
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 16.0¢ | $10.82K | 65.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4450 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 88474 | 2 |
View Market Depth
| Last trade - 15.32pm 20/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |